Systemic Radiotherapy with Monoclonal Antibodies
Springer Berlin (Verlag)
978-3-540-60209-5 (ISBN)
Lese- und Medienproben
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Summary of contents:
1. High dose radioimmunotherapy in malignant lymphoma
2. Treatment of patients with recurrent malignant gliomas with intratumoural radioimmunoconjugates
3. Two approaches for enhancing radioimmunotherapy: emitters and hyperthermia
4. Use of epidermal growth factor receptor
5. 425 monoclonal antibodies radiolabelled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain, treatment of diffuse leptomeningal malignanca by intrathecal injection of 1311-radioimmunoconjugates
6. Higher efficiency of 1311-labeled anti-carcinoembryonic antigen-monoclonal antibodies (Fab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude-mice
7. Problems and advances in the dosimetry of radionuclide targeted therapy
8. Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiation
9. Monoclonal antibodies in tumour therapy
10. Use of radioimmunotherapy in combination with bioreductive agents
11. Optimal therapeutic strategies for radioimmunotherapy
12. Minimal residual disease
13. Can preirradation enhance uptake of radiolabelled pharmaceuticals?
Reihe/Serie | Recent Results in Cancer Research |
---|---|
Zusatzinfo | 56 figs., 20 tabs. |
Sprache | englisch |
Gewicht | 442 g |
Einbandart | gebunden |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
Schlagworte | Antikörper • Dosimetrie • HC/Medizin/Klinische Fächer • Radioimmunologie • Strahlentherapie • Strahlentherapie / Radiotherapie |
ISBN-10 | 3-540-60209-7 / 3540602097 |
ISBN-13 | 978-3-540-60209-5 / 9783540602095 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich